What causes pseudogout

What is Pseudogout?

Pseudogout, medically termed calcium pyrophosphate deposition (CPPD) disease, is a form of inflammatory arthritis. It is characterized by the sudden onset of joint pain, swelling, and redness, often mimicking the symptoms of gout. However, unlike gout, which is caused by uric acid crystals, pseudogout is triggered by the deposition of calcium pyrophosphate (CPP) crystals within the joints, most commonly affecting the knees, wrists, and hips.

What Causes Pseudogout?

The exact cause of pseudogout isn't always clear, but it is fundamentally linked to the formation and accumulation of calcium pyrophosphate (CPP) crystals in the cartilage and other tissues within the joints. These crystals form when there is an imbalance in the levels of calcium and pyrophosphate in the body's fluids.

The Role of Calcium Pyrophosphate Crystals

Normally, calcium and pyrophosphate are present in the body's fluids, including the synovial fluid that lubricates joints. In individuals with pseudogout, these substances can combine to form microscopic crystals. While the precise mechanism is not fully understood, it's believed that these crystals can irritate the joint lining (synovium), triggering an inflammatory response. This inflammation leads to the characteristic symptoms of a pseudogout attack, such as severe pain, swelling, warmth, and redness in the affected joint.

Factors Contributing to Crystal Formation

Several factors can contribute to the development of CPP crystals and, consequently, pseudogout:

1. Aging

Age is one of the most significant risk factors for developing pseudogout. The prevalence of CPPD disease increases substantially with age. By the time people reach their 60s and 70s, the cartilage in their joints undergoes natural degenerative changes, which may make it more susceptible to crystal formation. Studies indicate that a significant percentage of individuals over the age of 60 have CPP crystals in their joints, although not all of them will develop symptomatic pseudogout.

2. Genetics and Heredity

In some instances, pseudogout can have a genetic component. Certain individuals may inherit a predisposition that makes them more likely to develop CPPD disease. This is particularly true for rare, early-onset forms of the condition. If a family member has a history of pseudogout or CPPD disease, the risk may be slightly elevated for other family members.

3. Metabolic and Endocrine Disorders

Certain underlying medical conditions that affect the body's metabolism can increase the risk of pseudogout. These include:

• Hypoparathyroidism: This condition involves insufficient production of parathyroid hormone, which regulates calcium and phosphate levels in the blood. Low parathyroid hormone can lead to higher levels of calcium and phosphate, promoting crystal formation.
• Hypercalcemia: Elevated calcium levels in the blood, from various causes, can also contribute.
• Hemochromatosis: An inherited disorder characterized by excessive iron absorption and storage in the body. Iron overload can affect cartilage and potentially influence crystal formation.
• Gout: While distinct conditions, having gout (caused by uric acid crystals) might sometimes be associated with an increased risk of developing pseudogout.
• Other metabolic conditions: Conditions like Wilson's disease (copper metabolism disorder) and ochronosis (alkaptonuria) have also been linked, though less commonly.

4. Joint Damage and Trauma

Previous injury or surgery to a joint can sometimes predispose that joint to the development of pseudogout. Damage to the cartilage may alter its composition or structure, making it a more favorable environment for CPP crystal deposition. An acute attack of pseudogout can also be triggered by trauma to an already affected joint.

5. Other Factors

While less common or definitively proven, other factors such as certain medications (e.g., diuretics) or even dehydration might play a role in triggering an acute attack in susceptible individuals. However, the primary drivers remain crystal formation due to aging, genetics, or underlying metabolic issues.

Understanding the Difference from Gout

It's crucial to distinguish pseudogout from gout. Both cause sudden, painful joint inflammation, but the underlying cause is different. Gout is caused by monosodium urate (MSU) crystals, which form when there's too much uric acid in the blood. Pseudogout is caused by calcium pyrophosphate (CPP) crystals. This distinction is important for diagnosis and treatment, as the management strategies can differ.

Diagnosis and Management

Diagnosing pseudogout typically involves analyzing synovial fluid from the affected joint using a technique called joint aspiration. Microscopic examination can identify the characteristic CPP crystals. Treatment focuses on relieving pain and inflammation during an acute attack, often with nonsteroidal anti-inflammatory drugs (NSAIDs), colchicine, or corticosteroids. Long-term management may involve addressing any underlying conditions contributing to crystal formation and, in some cases, medications to prevent future attacks.